Navigation Links
Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
Date:10/18/2007

SEATTLE, Oct. 19 /PRNewswire/ -- The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit scientific research institute, recently received a $252,000 grant from the M.J. Murdock Charitable Trust for core research equipment.

The Murdock Trust grant will enable IDRI to assemble an equipment core to enhance its basic research on immune responses against infectious diseases. IDRI's mission is to research and develop technologies to be used against diseases that continue to burden individuals and countries in the developing world.

IDRI projects enabled under the Murdock grant are focused on chronic infections resulting in leishmaniasis, tuberculosis, trachoma, Buruli ulcer, leprosy, and Chagas disease. Together, these diseases present major public health burdens and cause premature death or disability.

Targeted Diseases

-- Leishmaniasis, transmitted by the bite of a sandfly and caused by

Leishmania infection, is endemic in 88 countries. Approximately

15 million new cases of leishmaniasis occur each year. Visceral

leishmaniasis, which causes damage to internal organs, is often fatal

if left untreated.

-- Tuberculosis is a worldwide health problem. Caused by Mycobacterium

tuberculosis infection, every fifteen seconds someone in the developing

world dies of tuberculosis.

-- Leprosy is endemic in areas of Indian, Brazil, Philippines, the

Democratic Republic of Congo, Madagascar, Mozambique, Nepal, and

Tanzania. It is caused by Mycobacterium leprae infection.

-- Chagas disease, caused by Typanosoma cruzi infection, is endemic in

21 countries in Latin America. It is estimated that 18 million people

are affected by this chronic inflammatory disease, which affects the

heart and digestive tract and in some cases results in death.

-- Malaria, a major parasitic disease, is particularly devastating to

children in Africa.

New Equipment and Uses

The Murdock Trust core equipment grant will enable IDRI to purchase large equipment that is difficult to obtain with conventional research grant funding. Once implemented, the equipment core will enable IDRI's researchers to engage in high-throughput and state-of-the-art assays. Expanding IDRI's basic research equipment core will facilitate the investigation of pathogen- induced immune responses and will help identify new treatment strategies for target infections.

"We are confident we can effectively use this generous grant from the Murdock Trust to perform much needed research about diseases that plague so many millions of people around the world," says Steve Reed, Founder and Head of Research and Development of IDRI.

About M.J. Murdock Charitable Trust

The M.J. Murdock Charitable trust was established in 1975 by the late Melvin J. (Jack) Murdock, who co-founded Tektronix, Inc. of Beaverton, Oregon, and resided in Vancouver, Washington. The mission of the Murdock Charitable Trust is to enrich the quality of life in the Pacific Northwest by providing grants to organizations that seek to strengthen the region's educational and cultural base in creative and sustainable ways. Although the major funding interests are education and scientific research, grants are also given to a wide variety of organizations, including those that serve the arts, public affairs, health and medicine, human services, and people with disabilities.

The Murdock Charitable Trust has focused its grant-making efforts in the following five states of the Pacific Northwest: Alaska, Idaho, Montana, Oregon, and Washington. Beyond grant-making and investment, the Murdock Charitable Trust functions to convene groups of people to discuss issues of mutual interest. This practice is of great assistance to the Murdock Charitable Trust in exploring ways of responding to new grant-making opportunities consistent with its mission and, in addition, promotes a sharing of ideas and networking among participants.

For more information, see: http://www.murdock-trust.org/

About IDRI

IDRI is a non-profit organization committed to developing technologies to treat "neglected" diseases that place a significant burden on those living in the developing world. IDRI achieves its mission by working closely with industry, universities, and hospitals in developed and developing countries, government and private funding agencies, and the World Health Organization. For more information, go to http://www.idri.org.


'/>"/>
SOURCE Infectious Disease Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. eMetagens infectious disease technology licensed by WARF
2. Entrepreneurial Spirit Infectious in Milwaukee
3. New PCR Primers for Human Diseases
4. Identification of Disease Causing Mutations in Phenylketonuria by Denaturing Gradient Gel Electrophoresis Using the DCode System
5. Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma
6. Th1 and Th2 Balance, Regulation, and Involvement in Disease
7. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
8. Medical College receives $377K to study brain disease
9. Thompsons HHS legacy will include efforts to combat disease in Africa
10. Stem cells produce anti-disease protein in brain experiment
11. Neurognostics pushes early prediction of brain disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... an innovation leader in attendance control systems is proud to announce the introduction of ... make sure the right employees are actually signing in, and to even control the ... ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):